Prosecution Insights
Browse Companies Examiners Firms Draft Your Response
Home / Amgen, Inc.
Last updated: May 29, 2026

Amgen, Inc.

77 pending office actions • 39 art units • 70 examiners • 0 of 77 (0%) have an AI response strategy ready • 139 patents granted in the last 365 days

Portfolio Summary

77
Total Pending OAs
47
Non-Final OAs
28
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 75 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

39
Overdue
4
Due this week
21
Due this month
6
Due in next 60 days
5
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 75 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (39)Due ≤ 7 days (4)Due ≤ 30 days (21)Due ≤ 60 days (6)Due later (5)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
47
Medium (61%)
5
Easy (6%)
25
Unknown (32%)

Rejection Statute Mix

BucketCases
§103 only43 (56%)
§102 only3 (4%)
§112 only5 (6%)
Double-patenting + other1 (1%)
No statute on record25 (32%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

61
Life Sciences
79% of docket
3
Information Tech
4% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
13
Mechanical / Eng
17% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

770 h
Manual time on pending OAs
154 h
Time saved (low, 20%)
270 h
Time saved (mid, 35%)
6.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WEN, SHARON X 3 56.5% +32.8%
STONEBRAKER, ALYSSA RAE 2 54.4% +52.8%
KIM, YUNSOO 2 65.6% +35.2%
MARRISON, SAMUEL JOSEPH 2 69.2% +49.7%
SCHULTZHAUS, JANNA NICOLE 2 33.3% +40.2%
LALONDE, ALEXANDRA ELIZABETH 2 70.3% +34.1%
SIMMONS, CHRIS E 1 34.6% +19.5%
EVANS, ASHLEY ELIZABETH 1 10.0% +29.9%
SCHNURR, JOHN R 1 72.0% +10.6%
WANG, CHANG YU 1 33.6% +53.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18807705 MACHINE LEARNING (ML)-BASED SYSTEMS AND METHODS FOR PREDICTING DISEASE EVANS, ASHLEY ELIZABETH 39d

Interview Candidates (17)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17928561 ANTIBODY FORMULATIONS AND USES THEREOF KIM, YUNSOO 85d overdue
17609363 MODULATING ANTIBODY EFFECTOR FUNCTIONS STONEBRAKER, ALYSSA RAE 74d overdue
17599656 PREDICTING CELL CULTURE PERFORMANCE IN BIOREACTORS SCHULTZHAUS, JANNA NICOLE 36d overdue
13931716 METHODS FOR TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS WEN, SHARON X 18d overdue
18178086 CHIMERIC RECEPTORS AND METHODS OF USE THEREOF STONEBRAKER, ALYSSA RAE 8d overdue
17264139 INTERVENTIONAL DOSING SYSTEMS AND METHODS MARRISON, SAMUEL JOSEPH 4d overdue
18577109 TELEPRESENCE DEVICES, SYSTEMS AND METHODS SCHNURR, JOHN R 2d overdue
17284551 AUTOMATIC CALIBRATION AND AUTOMATIC MAINTENANCE OF RAMAN SPECTROSCOPIC MODELS FOR REAL-TIME PREDICTIONS SCHULTZHAUS, JANNA NICOLE 6d

Top Art Units

Art UnitApps
3783 9
1641 7
1647 5
1675 4
1642 4
1674 3
1625 2
1624 2
1635 2
1627 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19281019 SYNTHESIS OF KEY INTERMEDIATE OF KRAS G12C INHIBITOR COMPOUND SIMMONS, CHRIS E 1622 DPOther Final Rejection 75d Pending Jul 25, 2025
18807705 MACHINE LEARNING (ML)-BASED SYSTEMS AND METHODS FOR PREDICTING DISEASE EVANS, ASHLEY ELIZABETH 3687 §103 Final Rejection 39d Pending Aug 16, 2024
18577109 TELEPRESENCE DEVICES, SYSTEMS AND METHODS SCHNURR, JOHN R 2425 §103 Non-Final OA 2d overdue Pending Jan 05, 2024
18545688 PAC1 ANTIBODIES AND USES THEREOF WANG, CHANG YU 1675 Other Final Rejection 36d Pending Dec 19, 2023
18535068 FORMULATIONS OF HUMAN ANTI-RANKL ANTIBODIES, AND METHODS OF USING THE SAME LANDSMAN, ROBERT S 1647 Other Non-Final OA 21d Pending Dec 11, 2023
18525039 METHODS OF ANTIBODY PRODUCTION NGUYEN, JOHN P 1619 §103 Non-Final OA 70d Pending Nov 30, 2023
18562107 SOTORASIB DOSING REGIMEN CHANDRAKUMAR, NIZAL S 1625 Other Non-Final OA 18d overdue Pending Nov 17, 2023
18503009 DOSING REGIMEN OF KRAS G12C INHIBITOR AULAKH, CHARANJIT 1621 Other Non-Final OA 26d overdue Pending Nov 06, 2023
18502780 NOVEL PRMT5 INHIBITORS COLEMAN, BRENDA LIBBY 1624 §112 Non-Final OA 71d overdue Pending Nov 06, 2023
18288549 METHOD OF OPTIMIZING A FILLING RECIPE FOR A DRUG CONTAINER SEIF, DARIUSH 3731 §103 Final Rejection 29d Pending Oct 26, 2023
18371318 SYSTEMS AND METHODS FOR ESTIMATING TUMOR GROWTH LAGOY, KYRA RAND 3685 §103 Final Rejection 57d Pending Sep 21, 2023
18241564 LEAN PERFUSION CELL CULTURE METHODS BARRON, SEAN C 1653 Other Final Rejection — Pending Sep 01, 2023
18226414 DRUG DELIVERY DEVICE WITH STERILE FLUID FLOWPATH AND RELATED METHOD OF ASSEMBLY FLICK, JASON E 3783 §112 Non-Final OA 31d overdue Pending Jul 26, 2023
18357495 RNAI CONSTRUCTS AND METHODS FOR INHIBITING FAM13A EXPRESSION YU, DAVID TUYANG 1635 §103 Non-Final OA 71d Pending Jul 24, 2023
18224463 FORMULATED RECEPTOR POLYPEPTIDES AND RELATED METHODS MCCOLLUM, ANDREA K 1674 §103 Non-Final OA 37d overdue Pending Jul 20, 2023
18270581 USE OF KRAS G12C INHIBITOR IN TREATING CANCERS HASTINGS, ALISON AZAR 1627 Other Non-Final OA 23d overdue Pending Jun 30, 2023
18266689 DIFFUSION GRADIENT ASSAY FOR ANTI-CD3-CONTAINING MOLECULES SPENCE, JENNIFER SUZANNE 1633 §103 Non-Final OA 12d Pending Jun 12, 2023
18255575 TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS PECKHAM, RICHARD GRANT 1627 §112 Non-Final OA 46d overdue Pending Jun 01, 2023
18038579 ENANTIOSELECTIVE ALKENYLATION OF ALDEHYDES MOORE, SUSANNA 1624 §103 Non-Final OA 16d Pending May 24, 2023
18038041 COMPUTER SURROGATE MODEL TO PREDICT THE SINGLE-PHASE MIXING QUALITY IN STEADY STATE MIXING TANKS RUTTEN, JAMES D 2121 §103 Non-Final OA 23d overdue Pending May 22, 2023
18316739 Antibody Constructs for CLDN18.2 and CD3 MOSELEY II, NELSON B 1642 §112 Non-Final OA 8d overdue Pending May 12, 2023
18251553 MATERIALS AND METHODS FOR PROTEIN PROCESSING BANERJEE, KOYELI 1658 Other Non-Final OA 13d Pending May 03, 2023
18035016 METHODS FOR DECREASING MORTALITY RISK AND IMPROVING HEALTH ALABI, OYELEYE A 1797 §103 Non-Final OA 23d Pending May 02, 2023
18035054 METHODS FOR ADMINISTERING A BCMAXCD3 BINDING MOLECULE HADDAD, MAHER M 1641 Other Non-Final OA 7d Pending May 02, 2023
18034620 OVEREXPRESSION OF INSULIN-LIKE GROWTH FACTOR RECEPTOR MUTANTS TO MODULATE IGF SUPPLEMENTATION RAHMAN, MASUDUR 1633 §103 Non-Final OA 25d overdue Pending Apr 28, 2023
18026678 METHODS OF PROCESSING A SAMPLE FOR PEPTIDE MAPPING ANALYSIS ARMATO JR, DENNIS IGNATIUS 1651 §103 Final Rejection 33d Pending Mar 16, 2023
18245004 METHODS OF DETECTING ISOASPARTIC ACID XU, XIAOYUN 1797 §103 Final Rejection 28d Pending Mar 13, 2023
18178086 CHIMERIC RECEPTORS AND METHODS OF USE THEREOF STONEBRAKER, ALYSSA RAE 1642 Other Non-Final OA 8d overdue Pending Mar 03, 2023
18042267 ANTIGEN BINDING PROTEINS WITH NON-CANONICAL DISULFIDE IN FAB REGION BRISTOL, LYNN ANNE 1643 §103 Non-Final OA 93d overdue Pending Feb 20, 2023
18018389 CELL CULTURE MEDIA AND METHODS OF MAKING AND USING THE SAME VAN BUREN, LAUREN K 1638 §103 Non-Final OA 153d overdue Pending Jan 27, 2023
18097725 SYSTEMS AND METHODS FOR DELAYED DRUG DELIVERY ZAMORY, JUSTIN L 3783 §103 Non-Final OA 44d overdue Pending Jan 17, 2023
17928561 ANTIBODY FORMULATIONS AND USES THEREOF KIM, YUNSOO 1641 Other Non-Final OA 85d overdue Pending Nov 29, 2022
17923347 Deep Learning Platforms for Automated Visual Inspection HICKS, AUSTIN JAMES 2142 §103 Non-Final OA 22d Pending Nov 04, 2022
17774125 METHODS FOR TREATING LEUKEMIA BENAVIDES, JENNIFER ANN 1675 Other Non-Final OA 12d Pending Oct 31, 2022
17921793 PHARMACEUTICAL FORMULATION KAUFMAN, CLAIRE M 1674 Other Non-Final OA 17d overdue Pending Oct 27, 2022
18046860 ACTIVATABLE POLYPEPTIDE COMPLEX LOCKARD, JON MCCLELLAND 1647 Other Non-Final OA 34d Pending Oct 14, 2022
17916843 Synthesis of vinylic alcohol intermediates HAVLIN, ROBERT H 1626 §103 Non-Final OA 15d overdue Pending Oct 04, 2022
17913629 MONOCLONAL ANTIBODIES TO CHEMICALLY-MODIFIED NUCLEIC ACIDS AND USES THEREOF EMCH, GREGORY S 1678 §103 Non-Final OA 31d overdue Pending Sep 22, 2022
17910653 DETERMINATION OF FREE N-TERMINUS OF PEGFILGRASTIM USING AN ACID PROTEASE MISHRA, DEEPA 1657 §103 Non-Final OA 27d Pending Sep 09, 2022
17821835 Method of Antigen-Binding Protein Production MARCSISIN, ELLEN JEAN 1677 Other Non-Final OA 182d overdue Pending Aug 24, 2022
17798531 OMECAMTIV MECARBIL TABLET GHALI, ISIS A D 1611 §103 Final Rejection 29d Pending Aug 09, 2022
17778361 NOVEL MULTISPECIFIC ANTIBODY FORMAT DONOGHUE, BRITTNEY ERIN 1675 §102 Non-Final OA 19d overdue Pending May 19, 2022
17775386 Method for Reduced Aggregate Formation in Downstream Processing of Bispecific Antigen-Binding Molecules SKELDING, ZACHARY S 1644 §103 Non-Final OA 52d overdue Pending May 09, 2022
17775520 DOSING REGIMEN FOR ANTI-DLL3 AGENTS BERHANE, SELAM 1675 §103 Final Rejection 4d overdue Pending May 09, 2022
17775063 ENGINEERING CHARGE PAIR MUTATIONS FOR PAIRING OF HETERO-IgG MOLECULES DUFFY, BRADLEY 1643 §102 Final Rejection 45d overdue Pending May 06, 2022
17775257 METHOD OF TREATING OR AMELIORATING CUSHING'S SYNDROME USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) ALLEN, MARIANNE P 1647 Other Non-Final OA 87d overdue Pending May 06, 2022
17773892 HIGH SALT WASHES DURING CATION EXCHANGE CHROMATOGRAPHY TO REMOVE PRODUCT-RELATED IMPURITIES SHELTON, SYNPHANE LA'SHAWN 1652 §103 Non-Final OA 1d overdue Pending May 03, 2022
17773886 HIGH SALT LOAD CONDITIONING DURING CATION EXCHANGE CHROMATOGRAPHY TO REMOVE PRODUCT-RELATED IMPURITIES DEBERRY, REGINA M 1647 Other Non-Final OA 88d overdue Pending May 03, 2022
17771313 COMPOSITIONS AND METHODS FOR MINIMIZING PROTEIN LOSS AT LOW PROTEIN CONCENTRATIONS XIE, XIAOZHEN 1674 §103 Final Rejection 5d Pending Apr 22, 2022
17770349 DRUG DELIVERY SYSTEM AND METHOD OF USE WITTLIFF, KATERINA ANNA 3783 §103 Non-Final OA 27d Pending Apr 20, 2022
17770320 SYSTEMS AND COMPONENTS FOR DRUG DELIVERY AND COMPONENTS FOR PREPARATION OF THE SAME KIM, ERIN ASA 3781 §103 Non-Final OA 16d overdue Pending Apr 20, 2022
17763824 METHODS OF PRODUCING ANTIBODY COMPOSITIONS IVICH, FERNANDO NMN 1678 §112 Final Rejection 7d Pending Mar 25, 2022
17641736 Purification Method for Bispecific antigen-binding Polypeptides with Enhanced Protein L Capture Dynamic Binding Capacity HUYNH, PHUONG N 1641 §103 Non-Final OA 16d Pending Mar 09, 2022
17690038 DRUG DELIVERY DEVICE NICHOLS, CHARLES W 3783 §103 Non-Final OA 28d Pending Mar 09, 2022
17640177 IL-22 ORAL, INTRA-RECTAL, OR OTHER GUT-RELATED COMPOSITIONS AND METHODS OF USE THEREOF GURLEY, JAMI MICHELLE 1647 §102 Non-Final OA 60d overdue Pending Mar 03, 2022
17632330 KIF18A INHIBITORS MAHLUM, JONATHAN DAVIS 1625 Other Final Rejection 60d overdue Pending Feb 02, 2022
17630270 DRUG DELIVERY DEVICE WITH CONFIGURABLE NEEDLE SHIELD ENGAGEMENT COMPONENTS AND RELATED METHODS MARRISON, SAMUEL JOSEPH 3783 §103 Final Rejection 26d Pending Jan 26, 2022
17626688 DRUG DELIVERY SYSTEM WITH ADJUSTABLE INJECTION TIME AND METHOD OF USE ALLEN, ROBERT F 3783 §103 Final Rejection — Pending Jan 12, 2022
17624824 MULTISPECIFIC TRANSTHYRETIN IMMUNOGLOBULIN FUSIONS LEE, JIA-HAI 1658 Other Non-Final OA 30d overdue Pending Jan 04, 2022
17616234 AUTOMATED BIOMASS-BASED PERFUSION CONTROL IN THE MANUFACTURING OF BIOLOGICS JOHNSON, KARA D 1632 §103 Non-Final OA 79d Pending Dec 03, 2021
17616366 METHODS OF IDENTIFYING ATTRIBUTES OF THERAPEUTIC PROTEINS SIMMONS, VALERIE MICHELLE 1758 §103 Final Rejection 12d Pending Dec 03, 2021
17615520 RNAI CONSTRUCTS FOR INHIBITING SCAP EXPRESSION AND METHODS OF USE THEREOF SULLIVAN, STEPHANIE LAUREN 1635 Other Non-Final OA 1d overdue Pending Nov 30, 2021
17609363 MODULATING ANTIBODY EFFECTOR FUNCTIONS STONEBRAKER, ALYSSA RAE 1642 Other Final Rejection 74d overdue Pending Nov 05, 2021
17599656 PREDICTING CELL CULTURE PERFORMANCE IN BIOREACTORS SCHULTZHAUS, JANNA NICOLE 1685 §103 Final Rejection 36d overdue Pending Sep 29, 2021
17436218 IN VIVO REVERSIBILITY OF HIGH MOLECULAR WEIGHT SPECIES FRITCHMAN, REBECCA M 1758 §103 Non-Final OA 8d Pending Sep 03, 2021
17401114 RNAi CONSTRUCTS AND METHODS FOR INHIBITING MARC1 EXPRESSION VYAS, KEYUR ANILKUMAR 1637 §103 Final Rejection 28d overdue Pending Aug 12, 2021
17284551 AUTOMATIC CALIBRATION AND AUTOMATIC MAINTENANCE OF RAMAN SPECTROSCOPIC MODELS FOR REAL-TIME PREDICTIONS SCHULTZHAUS, JANNA NICOLE 1685 Other Non-Final OA 6d Pending Apr 12, 2021
17281896 METHODS FOR REDUCING AGGREGATION OF BISPECIFIC ANTIBODIES KIM, YUNSOO 1641 §103 Non-Final OA 15d Pending Mar 31, 2021
17277533 PLATFORM ASSEMBLY PROCESS FOR DRUG DELIVERY DEVICE LALONDE, ALEXANDRA ELIZABETH 3783 §103 Final Rejection 65d Pending Mar 18, 2021
17264386 DOSING REGIMEN FOR BCMA-CD3 BISPECIFIC ANTIBODIES PETRASH, HILARY ANN 1644 Other Final Rejection 30d overdue Pending Jan 29, 2021
17264139 INTERVENTIONAL DOSING SYSTEMS AND METHODS MARRISON, SAMUEL JOSEPH 3783 §103 Final Rejection 4d overdue Pending Jan 28, 2021
17036690 DRUG DELIVERY DEVICE LALONDE, ALEXANDRA ELIZABETH 3783 §103 Final Rejection 22d Pending Sep 29, 2020
17011433 METHODS OF TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS WEN, SHARON X 1641 Other Final Rejection 33d Pending Sep 03, 2020
16964452 LOW PH PHARMACEUTICAL ANTIBODY FORMULATION SULLIVAN, DENNIS JOHN 1642 §103 Non-Final OA 21d Pending Jul 23, 2020
16763515 METHODS FOR PRODUCING PROTEIN PRODUCTS HURST, JONATHAN M 1799 §103 Final Rejection 162d overdue Pending May 12, 2020
14316587 METHODS FOR TREATING HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WEN, SHARON X 1641 Other Final Rejection 14d Pending Jun 26, 2014
13931716 METHODS FOR TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS WEN, SHARON X 1641 Other Final Rejection 18d overdue Pending Jun 28, 2013

Managing Amgen, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Data sourced from USPTO Patent File Wrapper (daily) and Office Action Archive (weekly). Analysis generated by IP Author.

Data: USPTO Patent File Wrapper (daily) • Office Action Archive (weekly) • 89M+ prosecution events

© 2026 IP Author — Browse Office Actions • Examiners • Companies • Firms

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month